- Home >
- Site Map
- About PMDA
- Our Philosophy
- Message from Chief Executive
- Outline of PMDA
- Who We Are
- What We Do
- History
- Organization
- List of Executives and Directors
- Profile of services 2009 (PDF)
- Annual Reports
- FY2008
- FY2007
- FY2006
- FY2005
- FY2004
- Mid-term Targets/Mid-term Plan
- Services of PMDA
- Drug and Medical Device Reviews
- Outline
- Approved Products
- List of Approved Products
- Review Reports of New Product Applications
- Package Inserts Database (in Japanese)
- Regulations and Procedures
- Accreditation of Foreign Manufacturers
- Master File System
- GMP
- QMS
- Notifications
- Ministerial Ordinances
- Other Regulatory Actions
- Application for Approval-Frequently Asked Questions (FAQ)
- ICH Information (in Japanese)
- Points to Be Considered by the Review Staff Involved in the Evaluation Process of New Drug (PDF)
- Post-marketing Safety
- Outline
- Safety Information
- MHLW Pharmaceuticals and Medical Devices Safety Information
- PMDA Medical Safety Information
- Other Information (in Japanese)
- Regulations (in Japanese)
- Relief Services for Adverse Health Effects
- Outline